Amgen (AMGN) Reports Q4 Beat
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $360.55 +0.62%
Revenue Growth %: +2.6%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +2.6%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported its Q4 results, with EPS coming in at $4.36, beating the consensus estimate of $4.12. Revenue grew 3% year-over-year to $6.85 billion, slightly missing the consensus estimate of $6.88 billion, driven by increased Other Revenue from the Eli Lilly and Company COVID-19 manufacturing collaboration.
Total product sales for Q4 decreased 1% year-over-year. Unit volumes increased 7% but were more than offset by lower net selling price and lower inventory levels.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment (AVAV) Tops Q4 EPS by 36c
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
- McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
